Adaptimmune Therapeutics PLC

CIK 1621227 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Adaptimmune Therapeutics PLC.

Recent SEC filings

FiledFormAccession number
Apr 22, 2026RW0001104659-26-046473
Feb 17, 2026SCHEDULE 13G0001019056-26-000043
Nov 14, 2025SCHEDULE 13G/A0001011438-25-000554
Nov 14, 2025EFFECT9999999995-25-003290
Nov 13, 2025424B30001193805-25-001571
Nov 13, 202515-12G0001104659-25-110847
Oct 28, 2025S-8 POS0001104659-25-103166
Oct 28, 2025S-8 POS0001104659-25-103163
Oct 28, 2025POS AM0001104659-25-103158
Oct 28, 2025S-8 POS0001104659-25-103165
Oct 28, 2025250001104659-25-102828
Oct 20, 20258-K0001104659-25-100618
Oct 8, 202530001104659-25-098032
Sep 26, 20258-K0001104659-25-093882
Sep 12, 20258-K0001104659-25-089558
Sep 8, 20258-K0001558370-25-011925
Sep 3, 202540001104659-25-087085
Sep 2, 20251440001104659-25-086007
Aug 29, 20258-K0001558370-25-011820
Aug 29, 20251440001104659-25-085819
Aug 29, 202540001104659-25-085820
Aug 19, 202540000950170-25-110254
Aug 19, 2025SCHEDULE 13G/A0000935836-25-000544
Aug 19, 2025SCHEDULE 13D/A0001072613-25-000670
Aug 15, 20251440001968582-25-000747